Literature DB >> 22744994

Is harmonica playing an effective adjunct therapy to pulmonary rehabilitation?

Jeffrey L Alexander1, Carolyn L Wagner.   

Abstract

PURPOSE: This randomized controlled trial examined the effect harmonica playing has on various clinical, psychosocial, and functional outcomes among chronic obstructive pulmonary disease (COPD) patients in pulmonary rehabilitation (PR).
METHOD: Twenty-eight participants (Age 69.9 ± 1.8; FEV1 Predicted 41.9 ± 2.0%) were recruited from an outpatient PR program. Participants were randomly assigned to one of two groups, traditional PR (C; n = 16) or traditional PR plus harmonica playing (HT; n = 9). The HT group was provided a harmonica and one-on-one instruction by PR staff. Patients were given practice exercises to perform for at least 5 minutes, but not exceeding 20 minutes twice/day, 5 days/week.
RESULTS: No significant differences were found between groups. The combined sample improved significantly in their perception of shortness of breath, quality of life, and distance walked in 6 minutes.
CONCLUSION: Harmonica playing does not significantly affect the clinical, psychosocial, or functional status of COPD patients enrolled in PR.
© 2012 Association of Rehabilitation Nurses.

Entities:  

Mesh:

Year:  2012        PMID: 22744994     DOI: 10.1002/rnj.33

Source DB:  PubMed          Journal:  Rehabil Nurs        ISSN: 0278-4807            Impact factor:   1.625


  3 in total

1.  Usefulness of harmonica playing to improve outcomes in patients with chronic obstructive pulmonary disease.

Authors:  Mary K Hart; Elizabeth Stewardson; Aayla K Jamil; Kristen M Tecson; Mark W Millard
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-06

Review 2.  Effect of "add-on" interventions on exercise training in individuals with COPD: a systematic review.

Authors:  Carlos A Camillo; Christian R Osadnik; Hans van Remoortel; Chris Burtin; Wim Janssens; Thierry Troosters
Journal:  ERJ Open Res       Date:  2016-03-29

3.  Playing the harmonica with chronic obstructive pulmonary disease. A qualitative study.

Authors:  Adam Lewis; Joy Conway; Jack Middleton; Chris K Startup; James Wyatt
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 2.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.